Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Healthcare CRO Services Market, by Service Type
1.4.2 North America Healthcare CRO Services Market, by End User
1.4.3 North America Healthcare CRO Services Market, by Therapeutic Area
1.4.4 North America Healthcare CRO Services Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Aug – 2020, Mar) Leading Players
Chapter 4. North America Healthcare CRO Services Market by Service Type
4.1 North America Clinical Research Services Market by Country
4.2 North America Early Phase Development Market by Country
4.3 North America Laboratory Services Market by Country
4.4 North America Consulting Services Market by Country
Chapter 5. North America Healthcare CRO Services Market by End User
5.1 North America Pharmaceutical Sector Market by Country
5.2 North America Medical Device Sector Market by Country
5.3 North America Academic Institutes Market by Country
Chapter 6. North America Healthcare CRO Services Market by Therapeutic Areas
6.1 North America Oncology Market by Country
6.2 North America CNS Disorder Market by Country
6.3 North America Cardiovascular Disease Market by Country
6.4 North America Diabetes Market by Country
6.5 North America Metabolic Diseases Market by Country
6.6 North America Infectious Diseases Market by Country
6.7 North America Other therapeutic areas Market by Country
Chapter 7. North America Healthcare CRO Services Market by Country
7.1 US Healthcare CRO Services Market
7.1.1 US Healthcare CRO Services Market by Service Type
7.1.2 US Healthcare CRO Services Market by End User
7.1.3 US Healthcare CRO Services Market by Therapeutic Areas
7.2 Canada Healthcare CRO Services Market
7.2.1 Canada Healthcare CRO Services Market by Service Type
7.2.2 Canada Healthcare CRO Services Market by End User
7.2.3 Canada Healthcare CRO Services Market by Therapeutic Areas
7.3 Mexico Healthcare CRO Services Market
7.3.1 Mexico Healthcare CRO Services Market by Service Type
7.3.2 Mexico Healthcare CRO Services Market by End User
7.3.3 Mexico Healthcare CRO Services Market by Therapeutic Areas
7.4 Rest of North America Healthcare CRO Services Market
7.4.1 Rest of North America Healthcare CRO Services Market by Service Type
7.4.2 Rest of North America Healthcare CRO Services Market by End User
7.4.3 Rest of North America Healthcare CRO Services Market by End User
Chapter 8. Company Profiles
8.1 IQVIA Holdings, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.2 Laboratory Corporation of America Holdings (Covance, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.1 Recent strategies and developments:
8.2.1.1 Product Launches and Product Expansions:
8.2.1.2 Acquisition and Mergers:
8.2.1.3 Geographical Expansions:
8.3 Pharmaceutical Product Development, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Geographical Expansions:
8.3.4.2 Acquisition and Mergers:
8.3.4.3 Partnerships, Collaborations, and Agreements:
8.4 Parexel International Corporation (Pamplona Capital Management)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Acquisition and Mergers:
8.4.2.2 Partnerships, Collaborations, and Agreements:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.4.2 Partnerships, Collaborations, and Agreements:
8.6 ICON PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Product Launches and Product Expansions:
8.6.4.2 Acquisition and Mergers:
8.6.4.3 Partnerships, Collaborations, and Agreements:
8.7 Dassault Systemes SE (Medidata Solutions, Inc.)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Syneos Health, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Recent strategies and developments:
8.8.4.1 Partnerships, Collaborations, and Agreements:
8.9 Pharmaron Beijing Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.1 GVK Biosciences Private Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 